Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/25013
Title: Myoepithelial carcinoma of the breast arising in adenomyoepithelioma. A case report.
Authors: Yashar, Genghis
Basheska, Neli 
Ivkovski, Ljube
Kubelka, Katerina
Zografski, George
Keywords: breast
adenomyoepithelioma
myoepithelial carcinoma
histopathology
immunohistochemistry
Issue Date: Sep-2001
Publisher: Springer
Journal: Virchows Archiv
Conference: 18th European Congress of Pathology, September 8-13, 2001, Berlin, Germany
Abstract: Introduction: Adenomyoepithelioma (AME), and especially myoepithelial carcinoma (MC), the malignant variant of this tumor, is a rare breast neoplasm. This report comprises the pathological features of a breast MC arising in AME with an aggressive clinical course. Case report: A 48-year old woman with a palpable mass in the right breast was admitted in November 1998. A month later following FNAB, surgical excision was performed. During the follow-up period of 17 months, until the patient's death, two local recurrences developed. Despite the aggressive chemotherapy, administrated after the first recurrence, subsequently bone, pulmonary and brain metastases appeared. Results: The primary tumor was an ovoid, white-grey, encapsulated mass measuring 4x3,5x1,5 cm. Microscopically, this biphasic tumor was composed of rare tubules surrounded by interlacing bundles of spindle cells exhibiting mild atypia. It was initially classified as a benign phyllodes tumor. The immunohistochemical analyses performed after the second recurrence proved the myoepithelial origin of the neoplasm (S-100, cytokeratin and alpha-SMA positive cells), with a high mitotic index (11 MF/10 HPF), and an immunophenotype indicating aggressive biological potential (steroid receptor negative, 50% Ki-67 and 30% p53 positive cells). Therefore, it was reclassified as MC arising in spindle cell type of AME. Conclusion: The histopathological diagnosis of AME could be very difficult, especially when a distinction from other spindle cell breast neoplasms must be done. Immunohistochemistry is essential to confirm the diagnosis, having in mind the reported pathological characteristics and the immunohistochemical profile of recurrent and malignant tumors of this type.
URI: http://hdl.handle.net/20.500.12188/25013
DOI: 10.1007/BF02698641
Appears in Collections:Faculty of Medicine: Conference papers

Files in This Item:
File Description SizeFormat 
ECP 2001 pp451-2.pdf459.21 kBAdobe PDFView/Open
ECP 2001 cover.pdf75.39 kBAdobe PDFView/Open
Show full item record

Page view(s)

32
checked on Apr 26, 2024

Download(s)

8
checked on Apr 26, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.